Working… Menu

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04386616
Recruitment Status : Completed
First Posted : May 13, 2020
Last Update Posted : February 17, 2021
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2, 2021
Actual Study Completion Date : February 12, 2021